CAROLYN J PRESLEY

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology COLUMBUS, OH NPI 1285877894

General Payments — all program years on this page

$14,079.42

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 26
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $9,637.37 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $7,410.004
Travel and Lodging $1,593.014
Food and Beverage $634.3610

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $9,395.1614
JAZZ PHARMACEUTICALS INC. $118.381
Genentech, Inc. $62.761
Genentech USA, Inc. $46.491
Acerta Pharma LLC $14.581

By program year

Program yearAmountRecords
2022 $1,661.696
2023 $2,780.362
2024 $9,637.3718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101254054 E.R. Squibb & Sons, L.L.C. $2,070.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101254056 E.R. Squibb & Sons, L.L.C. $42.37 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101254058 E.R. Squibb & Sons, L.L.C. $30.00 03/21/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1101254060 E.R. Squibb & Sons, L.L.C. $1,200.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101254064 E.R. Squibb & Sons, L.L.C. $134.99 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101254066 E.R. Squibb & Sons, L.L.C. $64.99 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101254068 E.R. Squibb & Sons, L.L.C. $27.44 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101254070 E.R. Squibb & Sons, L.L.C. $49.99 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101254072 E.R. Squibb & Sons, L.L.C. $832.47 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1101254074 E.R. Squibb & Sons, L.L.C. $292.67 02/29/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1101254078 E.R. Squibb & Sons, L.L.C. $2,070.00 06/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101254084 E.R. Squibb & Sons, L.L.C. $437.87 07/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1101254086 E.R. Squibb & Sons, L.L.C. $2,070.00 07/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101254118 E.R. Squibb & Sons, L.L.C. $72.37 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104399771 AstraZeneca Pharmaceuticals LP $14.58 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132984893 Genentech USA, Inc. $46.49 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132984897 Genentech, Inc. $62.76 09/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150208050 JAZZ PHARMACEUTICALS INC. $118.38 09/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.